Jasmeer Chhatwal
Harvard University
H-index: 54
North America-United States
Top articles of Jasmeer Chhatwal
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Fluid biomarkers in cerebral amyloid angiopathy | Seyed Mehrdad Savar Bin Ma Eugene Hone Farzana Jahan Shaun Markovic | 2024/1/26 | |
Uncovering elevated tau TPP motif phosphorylation in the brain of Alzheimer's disease patients | Alzheimer's & Dementia | Jean‐Pierre Bellier Yuqi Cai Sarah M Alam Thorsten Wiederhold Arica Aiello | 2024/3 |
Identification of Fibrinogen as a Plasma Protein Binding Partner for Lecanemab Biosimilar IgG: Implications for Alzheimer's Disease Therapy | bioRxiv | Jean-Pierre Bellier Andrea Roman Caitlyn Christiano Juliana AU Anzai Stephanie Moreno | 2024 |
Presenilin‐1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage | Alzheimer's & Dementia | Nelly Joseph‐Mathurin Rebecca L Feldman Ruijin Lu Zahra Shirzadi Carmen Toomer | 2024/2/21 |
Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study | The Lancet Neurology | Julie K Wisch Nicole S McKay Anna H Boerwinkle James Kennedy Shaney Flores | 2024/5/1 |
Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial | JAMA neurology | Olivia Wagemann Haiyan Liu Guoqiao Wang Xinyu Shi Tobias Bittner | 2024 |
Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer’s disease | Brain | Hyun-Sik Yang Wai-Ying W Yau Becky C Carlyle Bianca A Trombetta Can Zhang | 2024/2/5 |
Deconstructing pathological tau by biological process in early stages of Alzheimer disease: a method for quantifying tau spatial spread in neuroimaging | Ebiomedicine | Stephanie Doering Austin McCullough Brian A Gordon Charles D Chen Nicole McKay | 2024/5/1 |
Investigation of sex differences in mutation carriers of the Dominantly Inherited Alzheimer Network | Alzheimer's & Dementia | Olivia Wagemann Yan Li Jason Hassenstab Andrew J Aschenbrenner Nicole S McKay | 2024/1 |
Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndrome | Alzheimer's & Dementia | Priyanka Gorijala M Muaaz Aslam Lam‐Ha T Dang L Xicota Maria V Fernandez | 2024/2 |
α‐Synuclein seed amplification assay detects Lewy body co‐pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burden | Alzheimer's & Dementia | Johannes Levin Simone Baiardi Corinne Quadalti Marcello Rossi Angela Mammana | 2024/4/26 |
Vascular contributions to cognitive decline: Beyond amyloid and tau in the Harvard aging brain study | Journal of Cerebral Blood Flow & Metabolism | Zahra Shirzadi Rory Boyle Wai-Ying W Yau Gillian Coughlan Jessie Fanglu Fu | 2024/3/7 |
First presentation with neuropsychiatric symptoms in autosomal dominant Alzheimer’s disease: the Dominantly Inherited Alzheimer’s Network Study | Journal of Neurology, Neurosurgery & Psychiatry | Antoinette O'Connor Helen Rice Josephine Barnes Natalie S Ryan Kathy Y Liu | 2023/5/1 |
Pattern and implications of neurological examination findings in autosomal dominant Alzheimer disease | Alzheimer's & Dementia | Jonathan Vöglein Nicolai Franzmeier John C Morris Marianne Dieterich Eric McDade | 2023/2 |
Reduced slow‐wave sleep is associated with greater tau accumulation and reduced cortical thickness in the temporal lobe | Alzheimer's & Dementia | Laura Stankeviciute Jasmeer P Chhatwal Raina Levin Valentina Pinilla Aaron P Schultz | 2023/12 |
Increased medial temporal tau positron emission tomography uptake in the absence of amyloid-β positivity | JAMA neurology | Alejandro Costoya-Sánchez Alexis Moscoso Jesús Silva-Rodríguez Michael J Pontecorvo Michael D Devous | 2023/10/1 |
Estimating a clinically normal individual’s position along a preclinical Alzheimer’s disease continuum using cognitive and amyloid trajectories | Alzheimer's & Dementia | Diana Townsend Michael J Properzi Tobey J Betthauser Hannah M Klinger Rory Boyle | 2023/12 |
White matter injury mediates the effects of PS1 mutation position on clinical measures in late disease stage | Alzheimer's & Dementia | Nelly Joseph‐Mathurin Ruijin Lu Zahra Shirzadi Jeremy F Strain Junie Saint Clair | 2023/12 |
Functional variations in gamma-secretase activity are critical determinants of the clinical, biomarker, and cognitive progression of autosomal dominant Alzheimer’s disease | bioRxiv | Stephanie A Schultz Lei Liu Aaron P Schultz Colleen D Fitzpatrick Raina Levin | 2023/7/5 |
Association of pathologic and volumetric biomarker changes with cognitive decline in clinically normal adults: Harvard Aging Brain Study | Neurology | Bernard J Hanseeuw Heidi IL Jacobs Aaron P Schultz Rachel F Buckley Michelle E Farrell | 2023/12/12 |
Co-Authors
